In this study, patients with HNSCC in the TCGA database were categorized based on CES1 expression levels into two groups: G1 (smokers with high CES1 expression) and G2 (smokers with low CES1 expression). This evidence concerns the gene CES1 and head and neck squamous cell carcinoma.